Pan J, McEver R P
Department of Medicine, W.K. Warren Medical Research Institute, University of Oklahoma, Oklahoma City, USA.
J Biol Chem. 1995 Sep 29;270(39):23077-83. doi: 10.1074/jbc.270.39.23077.
P-selectin, an adhesion receptor for leukocytes, is constitutively expressed by megakaryocytes and endothelial cells. Synthesis of P-selectin is also increased by some inflammatory mediators. We characterized a previously identified kappa B site (-218GGGGGTGACCCC-207) in the promoter of the human P-selectin gene. The kappa B site was unique in that it bound constitutive nuclear protein complexes containing p50 or p52, but not inducible nuclear protein complexes containing p65. Furthermore, the element bound recombinant p50 or p52 homodimers, but not p65 homodimers. Methylation interference analysis indicated that p50 or p52 homodimers contacted the guanines at positions -218 to -214 on the coding strand and at -210 to -207 on the noncoding strand. Changes in the three central residues at -213 to -211 altered binding specificity for members of the NF-kappa B/Rel family. Mutations that eliminated binding to NF-kappa B/Rel proteins reduced by approximately 40% the expression of a reporter gene driven by the P-selectin promoter in transfected bovine aortic endothelial cells. Overexpression of p52 enhanced P-selectin promoter activity, and co-overexpression of Bcl-3 further induced promoter activity in a kappa B site-dependent manner. In contrast, overexpression of p50 repressed promoter activity; this repression was prevented by co-overexpression of Bcl-3. Similar phenomena were observed with reporter gene constructs driven by two tandem P-selectin kappa B sequences linked to the SV40 minimal promoter. These data suggest that Bcl-3 differentially regulates the effects of p50 and p52 homodimers bound to the kappa B site of the P-selectin promoter. This site may be a prototype for kappa B elements in other genes that bind specifically to p50 and/or p52 homodimers.
P-选择素是白细胞的黏附受体,由巨核细胞和内皮细胞组成性表达。一些炎症介质也会增加P-选择素的合成。我们对人P-选择素基因启动子中一个先前鉴定的κB位点(-218GGGGGTGACCCC-207)进行了表征。该κB位点的独特之处在于它能结合含有p50或p52的组成型核蛋白复合物,而不是含有p65的诱导型核蛋白复合物。此外,该元件能结合重组p50或p52同二聚体,但不能结合p65同二聚体。甲基化干扰分析表明,p50或p52同二聚体与编码链上-218至-214位以及非编码链上-210至-207位的鸟嘌呤接触。-213至-211位三个中心残基的变化改变了对NF-κB/Rel家族成员的结合特异性。消除与NF-κB/Rel蛋白结合的突变使转染的牛主动脉内皮细胞中由P-选择素启动子驱动的报告基因的表达降低了约40%。p52的过表达增强了P-选择素启动子活性,而Bcl-3的共过表达以κB位点依赖的方式进一步诱导启动子活性。相反,p50的过表达抑制了启动子活性;Bcl-3的共过表达可阻止这种抑制。对于由与SV40最小启动子相连的两个串联P-选择素κB序列驱动的报告基因构建体,也观察到了类似现象。这些数据表明,Bcl-3差异调节与P-选择素启动子κB位点结合的p50和p52同二聚体的作用。该位点可能是其他基因中特异性结合p50和/或p52同二聚体的κB元件的原型。